NICE guidance: Why not clozapine for treatment-refractory bipolar disorder?

Tarun Bastiampillai; Arun Gupta; Stephen Allison; Sherry Kit Wa Chan

doi:10.1016/S2215-0366(16)30081-5

NICE guidance: Why not clozapine for treatment-refractory bipolar disorder?

Tarun Bastiampillai, Arun Gupta, Stephen Allison, Sherry Kit Wa Chan

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	502-503
Number of pages	2
Journal	The Lancet Psychiatry
Volume	3
Issue number	6
DOIs	https://doi.org/10.1016/S2215-0366(16)30081-5
Publication status	Published - 1 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2215-0366(16)30081-5Licence: In Copyright

Cite this

@article{ffdb64cec40b41d1801bca6bddc2cc0e,

title = "NICE guidance: Why not clozapine for treatment-refractory bipolar disorder?",

author = "Tarun Bastiampillai and Arun Gupta and Stephen Allison and Chan, {Sherry Kit Wa}",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/S2215-0366(16)30081-5",

language = "English",

volume = "3",

pages = "502--503",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - NICE guidance

T2 - Why not clozapine for treatment-refractory bipolar disorder?

AU - Bastiampillai, Tarun

AU - Gupta, Arun

AU - Allison, Stephen

AU - Chan, Sherry Kit Wa

PY - 2016/6/1

Y1 - 2016/6/1

UR - http://www.scopus.com/inward/record.url?scp=84971474753&partnerID=8YFLogxK

U2 - 10.1016/S2215-0366(16)30081-5

DO - 10.1016/S2215-0366(16)30081-5

M3 - Letter

C2 - 27262046

AN - SCOPUS:84971474753

SN - 2215-0366

VL - 3

SP - 502

EP - 503

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 6

ER -

NICE guidance: Why not clozapine for treatment-refractory bipolar disorder?

UN SDGs

Access to Document

Other files and links

Cite this